BUYINS.NET Issues Kindred Biosciences (KIN) SqueezeTrigger Report - iCrowdNewswire
  • Spain
  • Brazil
  • Russia
  • France
  • Germany
  • China
  • Korea
  • Japan

RSS Newsfeeds

See all RSS Newsfeeds

Global Regions

United States ( XML Feed )

Oct 7, 2016 10:19 AM ET

BUYINS.NET Issues Kindred Biosciences (KIN) SqueezeTrigger Report

Disclosure NewswireTM

iCrowdNewswire - Oct 7, 2016

October 7, 2016 / M2 PRESSWIRE / BUYINS.NET,, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on Kindred Biosciences (NASDAQ: KIN) after releasing the latest short sale data through October 5th, 2016. The total aggregate number of shares shorted since December 2013 is approximately 21.74 million shares. Approximately 32.53% of daily trading volume is short selling. The SqueezeTrigger price for all KIN shares shorted is $11.16. A total of 3.41 million shares ($13.54 million) have been shorted below the currently price of $4.97 and have begun squeezing.


Click here to view Report:


Click here for SqueezeTrigger:


Click here for Friction Factor:


Click here for detailed explanation:


Friction Factor calculates if a fair market is being made in the shares of KIN. 58% of the previous 38 trading days have been positive or bullish-biased and 42% have been negative or bearish-biased.


Regulation SHO requires bona-fide market-making activities to include making purchases and sales in roughly comparable amounts. The Commission has stated that bona-fide market-making DOES NOT include activity that is related to speculative selling strategies for investment purposes of the broker-dealer and is disproportionate to the usual market making patterns or practices of the broker-dealer in that security. Likewise, where a market-maker posts continually at or near the best offer, but does not also post at or near the best bid, the market-maker’s activities would not generally qualify as bona-fide market-making. Moreover, a market-maker that continually executes short sales away from its posted quotes would generally not be considered to be engaging in bona-fide market-making.


BUYINS.NET monitors KIN market-makers daily for compliance with Fair Market-Making Requirements.




BUYINS.NET,, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies and comparable valuations. Reports include:




Friction Factor – market-maker surveillance system tracking market-makers to determine Price Friction and compliance with new “Fair Market-Making Requirements”.


RegSHO Naked Shorts – tracks EVERY failure to deliver in all US stocks and all Threshold Security Lists daily for which stocks have naked short positions.




SqueezeTrigger – 40 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.


Earnings Edge – predicts probability, price move and length of move before and after all US stock earnings reports.


Seasonality – predicts probability, price move and length of move based on exact time of year for all US stocks.


Group Trader – tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.


Pattern Scanner – automates tracking of technical patterns and predicts next move in stocks.


GATS – tracks all strategies




BUYINS.NET is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. The Company has paid $1,250 per month for twelve months of data provided in this and subsequent reports. KIN has not approved the statements made in this release. Please read our report and visit our web site,, for complete risks and disclosures.



BUYINS.NET Thomas Ronk 800-715-9999 [email protected]

Contact Information:

Thomas Ronk, CEO
[email protected]

Keywords: biotech veterinary pets stock stocks trading trader invest investor investing
Tags: Disclosure Newswire, Public Companies / Stock Exchange Listed Companies, United States, English, Reg. FD
View Related News >